文献速递糖尿病

使用经济激励促进青少年1型糖尿病自我管理:一项先导性随机对照试验

Use of Financial Incentives to Promote Adolescent Type 1 Diabetes Self-management: A Pilot Randomized Controlled Trial.
PubMed 文献 · Diabetes Care · 2024-01-01

本先导性随机对照交叉试验在12至18岁1型糖尿病青少年中评估经济激励对自我管理行为和血糖的影响,比较获益框架、损失框架和无激励三种情况。结果显示获益框架和损失框架下行为目标达成率及范围内时间均高于无激励期,但三组间糖化血红蛋白无差异。作者认为经济激励可在短期内改善自我管理行为和范围内时间。

要点

  • 经济激励可短期提高1型糖尿病青少年的自我管理行为目标达成率。
  • 获益框架和损失框架下范围内时间均高于无激励期。
  • 三种情况下糖化血红蛋白无差异。

核心结论

  • 经济激励可在短期内改善1型糖尿病青少年的糖尿病自我管理行为和范围内时间。

研究设计与样本

  • 先导性三处理(获益框架、损失框架、无激励)交叉随机对照试验,纳入12至18岁1型糖尿病青少年,参与者自选激励性自我管理行为和临床结局目标,每个12周激励治疗组最多可赚取180美元。

主要发现

  • 无经济激励组平均行为目标达成率为41%,获益框架组为50%(P < 0.01),损失框架组为45%(P < 0.01)。
  • 无经济激励时平均范围内时间为38%,获益框架组为43%(P < 0.01),损失框架组为42%(P < 0.01)。
  • 三种情况之间糖化血红蛋白无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether financial incentives lead to improvement in self-management behaviors and glycemia in adolescents with type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS: Adolescents (12- to 18-year-olds) with T1D selected incentivized self-management behavior and clinical outcome goals in a three-treatment (gain frame, loss frame, no incentives) crossover randomized controlled trial. Participants could earn up to $180 in each 12-week incentive treatment arm. RESULTS: Compared with a mean 41% behavioral goal attainment within the nonfinancial incentives arm, mean behavioral goal attainment under gain and loss frames was 50% (P < 0.01) and 45% (P < 0.01), respectively. Mean time in range (TIR) in gain frame and loss frame arms was higher 43% (P < 0.01) and 42% (P < 0.01), respectively, compared with when not receiving financial incentives (38%). There was no difference in A1C among the three arms. CONCLUSIONS: Financial incentives can improve diabetes self-management behaviors and TIR in adolescents with T1D in the short-term.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Malik FS, Chen T, Manzueta M, et al. Use of Financial Incentives to Promote Adolescent Type 1 Diabetes Self-management: A Pilot Randomized Controlled Trial. Diabetes Care. 2024. PMID: 39110546. doi:10.2337/dc24-0699

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。